11-27-2018 11:50 AM CET - Health & Medicine
Print

Radiopharmaceuticals Market Research Studies, Competition Landscape and Recent Development 2019: Cardinal Health, MallinckrodtPlc, Bayer AG, Bracco Imaging SpA, Nordion, GE Healthcare, Lantheus Medical Imaging, IBA Molecular Imaging, CovidienPlc

Press release from: Data Bridge Market Research
Radiopharmaceuticals Market
Radiopharmaceuticals Market


The study of the “Global Radiopharmaceuticals Market” provides the market size information along with the factors and parameters impacting it in both short and long-term. The study ensures a 360° view, bringing out the complete key insights of the industry.

Global Radiopharmaceuticals Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes radiopharmaceuticals market shares for global, Europe, North America, Asia Pacific and South America.

In 2017, diagnostic radiopharmaceuticals segment dominate the market and is expected to grow at the highest in the forecast period. This is due to the production of MO-99 in the U.S., FDA approvals of radiopharmaceuticals, initiatives of International Atomic Energy Agency (IAEA), new irradiation facility in Germany, installation of PET scanners in India, andgovernment investments in Rest of Asia-Pacific.

Download PDF Sample Copy of Report Visit @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Market Definition:

Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent. Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy. The procedures and facilities for the production, use, and storage of radiopharmaceuticals are subject to licensing by national or regional authorities. This licensing includes compliance both with governing radioactive materials and with those regulations governing pharmaceutical preparations. Additional regulations may apply for issues such as transportation or dispensing of radiopharmaceuticals.

Target Audience:

• Hospitals,
• Ambulatory surgical centers,
• Diagnostic centers,
• Cancer research institutes and
• Others

Recent Developments:

Recent trends in the radiopharmaceuticals market such as growing disease which targeted cancer therapy, increasing awareness, expanding applications of molecular imaging, technological advancement, increasing trend of radio-labelled peptides and monoclonal antibodies for the diagnosis and treatment of cancer tumors and increasing use of SPECT & PET scans is expected to drive the market in the forecast period 2017 to 2024.

Radiopharmaceuticals are mostly used for treatment of cancer, bone pain, and thyroid cancer. In the U.S. cancer is second fatal disease whereas in the UK it is the leading cause of death. In most of the third world countries cancer appears much lower. Cancer is the second leading cause of death globally and was responsible for 8.8 million deaths in 2015. Globally, nearly 1 in 6 deaths is due to cancer. In 2016, an estimated 1.6 million new cases of cancer was diagnosed in the United States and 0.5 million people died from the disease.

On the other hand, shorter half-life of radiopharmaceuticals, stringent regulatory guidelines and competition from conventional diagnostic procedures are some of the factors which may hinder the growth of radiopharmaceuticals market.

"Global Radiopharmaceuticals Market" is predictable to reach USD 9.49 billion by 2024 from USD 4.87 billion in 2016, at a CAGR of 8.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Any Specific Requirements? Questions? Ask to Our Industry Expert @ databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Market Segmentation:

On the basis of type
• Diagnostic
• Therapeutic radiopharmaceuticals.

On the basis of procedural volumes

1. Diagnostic procedure
• Single-photon emission computed tomography (SPECT) radiopharmaceuticals
• Positron emission tomography (PET) radiopharmaceuticals

2. Therapeutic procedures
• Beta emitters
• Alpha emitters
• Brachy therapy

On the basis of application
1. Diagnostic application
• Single-photon emission computed tomography (SPECT)
• Positron emission tomography (PET)- oncology, cardiology, neurology and others

2. Therapeutic application
• Thyroid,
• Bone metastasis,
• Lymphoma,
• Endocrine tumours
• Others

On the basis of sources
• Nuclear reactors
• Cyclotrons

TABLE OF CONTENTS

1 INTRODUCTION

2 MARKET SEGMENTATION

3 MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS
5.1. VENDOR POSITIONING GRID AND INVESTMENT OPPORTUNITIES
5.2. TECHNOLOLGICAL ADVANCEMENTS
5.3. INSIGHTS ON TECHNOLOGICAL DEVELOPMENTS IN THE GLOBAL RADIOPHARMACEUTICALSMARKET
5.4. MARKET REGULATORY SCENARIO BY COUNTRY
5.5. INTERVIEW KEY INSIGHTS

6 GLOBAL RADIOPHARMACEUTICALS MARKET, BY TYPE

7 GLOBAL RADIOPHARMACEUTICALS MARKET, BY PROCEDURAL VOLUMES

8 GLOBAL RADIOPHARMACEUTICALS MARKET, BY APPLICATION

9 GLOBAL RADIOPHARMACEUTICALS MARKET, BY SOURCES

10 GLOBAL RADIOPHARMACEUTICALS MARKET, BY END-USER

11 GLOBAL RADIOPHARMACEUTICALS MARKET, BY GEOGRAPHY

12 GLOBAL RADIOPHARMACEUTICALS MARKET, COMPANY PROFILES
12.1 CARDINAL HEALTH INC.,
12.2 MALLINCKRODTPLC.,
12.3 GE HEALTHCARE
12.4 LANTHEUS MEDICAL IMAGING INC.,
12.5 BAYER AG,
12.6 COMPANY A
12.7 COMPANY B
12.8 COMPANY C
12.9 COMPANY D
11 APPENDIX
12 ABOUT DATA BRIDGE MARKET RESEARCH

Request for Table of Content of Full Report @ databridgemarketresearch.com/toc/?dbmr=global-radiopharma...

Top Challengers:

• Cardinal Health Inc.
• MallinckrodtPlc.
• GE Healthcare
• Lantheus Medical Imaging Inc.
• Bayer AG
• Bracco Imaging SpA
• Eczacibasi-Monrol Nuclear Products
• Nordion Inc.
• Advanced Accelerator Applications S.A.
• IBA Molecular Imaging
• Actinium Pharmaceuticals Inc.,
• Among others.

Related Report

North America Digital Health Monitoring Market – Industry Trends and Forecast to 2024

North America Digital Health Monitoring Market By Product Type Devices (Blood Pressure Monitors, Blood Glucose Monitors, ECG, Oximeters, Peak Flow Monitors, Multi Parameter Monitors, Sleep Neap Monitors, Neurological Monitors, Others), Software (Healthcare Apps, Chronic Disease Apps, Personal Health Apps, Others), Services (Remote Monitoring, Consultancy Services, Treatment Services, Fitness and Wellness Services, Others), By Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024

Report Access: databridgemarketresearch.com/reports/north-america-digita...

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1401852 • Views: 122
More releasesMore releases

You can edit or delete your press release here: